# Asimov–LG Chem licensing agreement

Asimov has signed a licensing agreement under which South Korea-based LG Chem will in-license Asimov's CHO Edge System to support its biologics cell line development. The system includes the recently announced Chrysalis transposase and Kernel, Asimov's AI-driven genetic design software. The deal puts AI-assisted genetic design and cell line construction tools into the hands of a chemical company with an existing life sciences business, but the two sides did not disclose deal value, exclusivity or the specific development stage.

Asimov has signed a licensing agreement under which South Korea-based LG Chem will in-license Asimov's CHO Edge System to support its biologics cell line development. The system includes the recently announced Chrysalis transposase and Kernel, Asimov's AI-driven genetic design software. The deal puts AI-assisted genetic design and cell line construction tools into the hands of a chemical company with an existing life sciences business, but the two sides did not disclose deal value, exclusivity or the specific development stage.